3T8-20247-58093
1 vaccination
3 coded responses
6 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 030 / NH
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-25
Dose 1 — Pfizer-BioNTech
-
2021-03-26
Registered in v-safe
-
2021-03-26
Survey response — days 1–6 daily, dose 1MedDRA: Emergency care, Rash — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Systemic reaction (other): Splotchy rash on face yesterday · Healthcare visit (other): Went to ER yesterday for face rashMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-27
Survey response — days 1–6 daily, dose 1MedDRA: Irritability, Rhinorrhoea — Feeling: Fair · Fever · Headache, Fatigue or tirednessFree text: Runny nose, irritabilityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-28
Survey response — days 1–6 daily, dose 1MedDRA: Irritability, Upper-airway cough syndrome — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Irritability, post nasal dripMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-28
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-03-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-03-30
-
2021-03-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-31
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-04-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-26 | Unsuccessful | |
| 2021-03-28 | priority 2/3 | |
| 2021-03-31 | priority 2/3 |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Splotchy rash on face yesterday
Healthcare visit (other): Went to ER yesterday for face rash
Systemic reaction (other): Runny nose, irritability
Systemic reaction (other): Irritability, post nasal drip
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Emergency care | ✓ | ✓ | ✓ |
| HCVO | Rash | ✓ | ✓ | ✓ |
| SRO | Irritability | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release